Xenon Pharmaceuticals to Present at the 2023 RBC Capital Markets Global Healthcare Conference
12 May 2023 - 06:01AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced that the company will
present at the 2023 RBC Capital Markets Global Healthcare
Conference taking place May 16-17, 2023 in New York, NY.
Company Fireside Chat Presentation Details:
Date: |
|
Tuesday, May 16, 2023 |
|
|
|
Time: |
|
3:05 pm Eastern Time / 12:05 pm Pacific Time |
|
|
|
Webcast: |
|
Register here |
|
|
|
Presenters: |
|
Ian Mortimer, President and CEOSherry Aulin, CFO |
|
|
|
A live webcast of the company presentation will
be available on the “Investors” section of Xenon's website and
posted for replay following the event. The above listed dates and
times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need,
with a focus on epilepsy. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi RegtsXenon
Pharmaceuticals Inc.Phone: 604.484.3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Feb 2024 to Mar 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Mar 2023 to Mar 2024